 |
|
|
|
|
 |
Last Updated: Sep 8, 2007 - 1:21:03 PM |
Latest Research
:
Haematology
:
Hemophilia
Hemophilia a silent killer
Even as the country focuses on headline-grabbing diseases, hemophilia, a little known blood disorder, is turning out to be a silent killer with over 50,000 people affected.
Apr 17, 2006 - 2:08:00 PM
|
Latest Research
:
Haematology
:
Hemophilia
Recombinant products are more safe for people with Bleeding Disorders
An international team of scientists, including a hematologist from Thomas Jefferson University in Philadelphia, has concluded that people with bleeding disorders such as hemophilia remain at risk from emerging infectious agents in plasma and blood transfusions. For this reason, recombinant therapies, that is, those produced in the laboratory, must always be an option.
Feb 14, 2006 - 5:04:00 PM
|
Latest Research
:
Haematology
:
Hemophilia
Hybrid baculovirus treats hemophilia in mouse models
A virus that typically infects insects could help with the development of gene therapy treatment for Hemophilia A, a condition in which even a bump on the knee can cause serious internal bleeding in people.
Aug 23, 2005 - 9:13:00 PM
|
Latest Research
:
Haematology
:
Hemophilia
Hope of an alternative treatment option for haemophilia sufferers
Haemophilia is a hereditary blood disease, primarily affecting males, where the blood fails to clot causing potentially life-threatening 'bleeds'. About one in 6000 Australian males is born with haemophilia in severe, moderate or mild form. People with haemophilia rely on intravenous infusion of recombinant Factor VIII clotting protein.
Aug 11, 2005 - 3:01:00 AM
|
Latest Research
:
Haematology
:
Hemophilia
Gene therapy to treat haemophilia
Cure achieved in dogs are humans next?
Aug 10, 2005 - 9:29:00 PM
|
<< prev
next >>
|
|
|
|
